Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Monte Rosa Therapeutics Has Dosed The First Participants In A Phase 1, Single Ascending Dose/Multiple Ascending Dose, Healthy Volunteer Study Of MRT-6160, A VAV1-directed MGD Being Developed For Systemic And Neurological Autoimmune Diseases, Initial Data Expected In Q1 2025

Author: Benzinga Newsdesk | August 19, 2024 07:11am

Posted In: GLUE